Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2755-2763

  Woods, J M ^a   Katschke K J , Jr ^a   Tokuhira, M ^a   Kurata, H ^a   Arai, K I ^a   Campbell, P L ^a   Koch, A E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; RANTES; RECOMBINANT INTERLEUKIN 13; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ADENOVIRUS; ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0034284226     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2755     Document Type: Article

References (53)

1. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis
2. Rheumatoid arthritis: Pathophysiology and implications for therapy
3. Gene transfer to synoviocytes: Prospects for gene treatment of arthritis
4. Effects of 1L-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: Comparison with IL-4 and modulation by IFN-γ, or 1L-10
5. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats
6. Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis
7. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
8. Use of the rat adjuvant-induced arthritis as a model for rheumatoid arthritis gene therapy
9. Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5
10. Construction of nondefective adenovirus type 5 beating a 2.8-kilobase hepatitis B virus DNA near the right end of its genome
11. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
12. Functional heterogeneity of human rheumatoid synovial tissue macrophages
13. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8
14. Growth-related gene product α: A chemotactic cytokine for neutrophils in rheumatoid arthritis
15. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function
16. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells
17. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis
18. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis
19. Direct gene delivery to synovium: An evaluation of potential vectors in vitro and in vivo
20. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo
21. Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo
22. Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: Inhibition by an IL-4 mutant protein
23. Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblasts
24. Modulation of proinflammatory cytokine production in tumour necrosis factor-α (TNF-α)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13
25. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13
26. Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells: Involvement of IL-4Rα and Star6 phosphorylation
27. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: Roles of tumor necrosis factor α, interleukin-1, and interleukin-8
28. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease
29. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-Ipr mouse model
30. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
31. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages
32. Interleukin 13 inhibits macrophage inflammatory protein-1 α production from human alveolar macrophages and monocytes
33. Interleukin-13 down-regulates the expression of neutrophil-derived macrophage inflammatory protein-1α
34. Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13
35. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: Regulation by T helper 2 cytokines and corticosteroids
36. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
37. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
38. Soluble intercellular adhesion molecule-1 in arthritis
39. Adhesion molecules in untreated inflammatory arthritis: Synovial expression and levels in synovial fluid and serum
40. Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts
41. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNT-α and is inhibited by IL-4 and IL-13
42. A cell's sense of direction
43. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: Suppression of IL-13 binding by IL-2 receptor γ chain
44. Defining therapeutic targets by using adenovirus: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares antiinflammatory mediators
45. Regulation of tumor necrosis factor α transcription in macrophages: Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB
46. Characterization of a functional NF-κB site in the human interleukin β promoter: Evidence for a positive autoregulatory loop
47. The NF-κB activation pathway: Its regulation and role in inflammation and cell survival
48. Function and activation of NF-κB in the immune system
49. The NF-κB and IκB proteins: New discoveries and insights
50. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13
51. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis
52. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes